eXoZymes Inc. Common Stock (EXOZ)

About EXOZ

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

32

Website

exozymes.com/

Fundamentals

1-day range

$6.71$7.38

Market cap

$47.57M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-1.15

Dividend yield

—

Beta

1.24

Avg. volume

9.5K

eXoZymes Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• EXOZ

  eXoZymes Inc. Common Stock

  $7.17

  ▼ 0.10%
  Market cap $47.57MP/E —
  $4.35$18.4
• MGX

  Metagenomi Therapeutics Inc. Common Stock

  $1.2

  ▼ 0.83%
  Market cap $46.68MP/E —
• ATYR

  aTyr Pharma Inc. Common Stock

  $0.5361

  ▼ 3.41%
  Market cap $49.22MP/E —
• TIL

  Instil Bio Inc. Common Stock

  $7.58

  ▼ 3.56%
  Market cap $49.37MP/E —
  $5.67$33.83
• OKYO

  OKYO Pharma Limited Ordinary Shares

  $1.67

  ▲ 7.74%
  Market cap $51.94MP/E —
  $1.34$3.2
• TVGN

  Tevogen Inc. Common Stock

  $6.89

  ▲ 2.07%
  Market cap $41.58MP/E —
  $3.64$49.5
• INKT

  MiNK Therapeutics Inc. Common Stock

  $11.43

  ▼ 2.16%
  Market cap $54.80MP/E —
  $8.48$16.98

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Thursday's After-Market Session
  Benzinga · 8/20/2026
• eXoZymes Says Optimized NCT Process Delivered 10-Fold Productivity Gain vs. 100-Liter Pilot, With About 67% More Output Per Liter
  benzinga · 8/18/2026
• eXoZymes to Host Second Quarter 2026 Update Conference Call on Thursday, August 20, 2026
  Yahoo · 8/11/2026

• Perriman Damien Alan · August 19, 2026 · Option Exercise

  19.6K
• Korman Tyler Paz · August 19, 2026 · Option Exercise

  33.0K
• Korman Tyler Paz · April 9, 2026 · Sale

  750 @ $10.53
• Korman Tyler Paz · April 8, 2026 · Sale

  750 @ $10.04
• Perriman Damien Alan · April 1, 2026 · Grant

  146.4K
• Perriman Damien Alan · April 1, 2026 · Grant

  62.8K
• Perriman Damien Alan · April 1, 2026 · Grant

  8.9K @ $8.44
• Opgenorth Paul Hideo · April 1, 2026 · Grant

  4.0K @ $8.44
• Nawaz Fouad · April 1, 2026 · Grant

  6.0K @ $8.44
• Korman Tyler Paz · April 1, 2026 · Grant

  5.3K @ $8.44

Institutional Ownership

March 31, 2026

Total shares held

53.5K

Total value held

$401.1K

Institutional holders

6